Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease | NobleBlocks
Public
Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease
N
Shared by NobleBlocks on Jun 12, 2024 • 12:00 AM UTC
